<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32629888</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Pro-Inflammatory Signaling Upregulates a Neurotoxic Conotoxin-Like Protein Encrypted Within Human Endogenous Retrovirus-K.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1584</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9071584</ELocationID><Abstract><AbstractText>Motor neuron degeneration and spinal cord demyelination are hallmark pathological events in Amyotrophic Lateral Sclerosis (ALS). Endogenous retrovirus-K (ERVK) expression has an established association with ALS neuropathology, with murine modeling pointing to a role for the ERVK envelope (<i>env</i>) gene in disease processes. Here, we describe a novel viral protein cryptically encoded within the ERVK <i>env</i> transcript, which resembles two distinct cysteine-rich neurotoxic proteins: conotoxin proteins found in marine snails and the Human Immunodeficiency Virus (HIV) Tat protein. Consistent with Nuclear factor-kappa B (NF-&#x3ba;B)-induced retrotransposon expression, the ERVK conotoxin-like protein (CTXLP) is induced by inflammatory signaling. CTXLP is found in the nucleus, impacting innate immune gene expression and NF-&#x3ba;B p65 activity. Using human autopsy specimens from patients with ALS, we further showcase CTXLP expression in degenerating motor cortex and spinal cord tissues, concomitant with inflammation linked pathways, including enhancement of necroptosis marker mixed lineage kinase domain-like (MLKL) protein and oligodendrocyte maturation/myelination inhibitor Nogo-A. These findings identify CTXLP as a novel ERVK protein product, which may act as an effector in ALS neuropathology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Curzio</LastName><ForeName>Domenico Di</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurm</LastName><ForeName>Mamneet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB R3E 0T5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turnbull</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadeau</LastName><ForeName>Marie-Jos&#xe9;e</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meek</LastName><ForeName>Breanna</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rempel</LastName><ForeName>Julia D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fineblit</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonasson</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hebert</LastName><ForeName>Sherry</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferguson-Parry</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douville</LastName><ForeName>Ren&#xe9;e N</ForeName><Initials>RN</Initials><Identifier Source="ORCID">0000-0002-7854-007X</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB R3E 0T5, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020916">Conotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020916" MajorTopicYN="N">Conotoxins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020077" MajorTopicYN="N">Endogenous Retroviruses</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079302" MajorTopicYN="N">Necroptosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012190" MajorTopicYN="N">Retroviridae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIV Tat</Keyword><Keyword MajorTopicYN="N">NF-&#x3ba;B</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">conotoxin</Keyword><Keyword MajorTopicYN="N">endogenous retrovirus</Keyword><Keyword MajorTopicYN="N">myelination</Keyword><Keyword MajorTopicYN="N">necroptosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32629888</ArticleId><ArticleId IdType="pmc">PMC7407490</ArticleId><ArticleId IdType="doi">10.3390/cells9071584</ArticleId><ArticleId IdType="pii">cells9071584</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xue Y.C., Feuer R., Cashman N., Luo H. Enteroviral Infection: The Forgotten Link to Amyotrophic Lateral Sclerosis? Front. Mol. Neurosci. 2018;11:63. doi: 10.3389/fnmol.2018.00063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00063</ArticleId><ArticleId IdType="pmc">PMC5857577</ArticleId><ArticleId IdType="pubmed">29593492</ArticleId></ArticleIdList></Reference><Reference><Citation>Celeste D.B., Miller M.S. Reviewing the evidence for viruses as environmental risk factors for ALS: A new perspective. Cytokine. 2018;108:173&#x2013;178. doi: 10.1016/j.cyto.2018.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2018.04.010</ArticleId><ArticleId IdType="pubmed">29684753</ArticleId></ArticleIdList></Reference><Reference><Citation>Sher R.B. The interaction of genetics and environmental toxicants in amyotrophic lateral sclerosis: Results from animal models. Neural Regen. Res. 2017;12:902&#x2013;905. doi: 10.4103/1673-5374.208564.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.208564</ArticleId><ArticleId IdType="pmc">PMC5514860</ArticleId><ArticleId IdType="pubmed">28761418</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson S.B., Downie J.M., Tsetsou S., Feusier J.E., Figueroa K.P., Bromberg M.B., Jorde L.B., Pulst S.M. The evolving genetic risk for sporadic ALS. Neurology. 2017;89:226&#x2013;233. doi: 10.1212/WNL.0000000000004109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004109</ArticleId><ArticleId IdType="pmc">PMC5513819</ArticleId><ArticleId IdType="pubmed">28642336</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Horton D.K., Mitsumoto H. Potential Environmental Factors in Amyotrophic Lateral Sclerosis. Neurol. Clin. 2015;33:877&#x2013;888. doi: 10.1016/j.ncl.2015.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.009</ArticleId><ArticleId IdType="pmc">PMC4646848</ArticleId><ArticleId IdType="pubmed">26515627</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville R., Liu J., Rothstein J., Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann. Neurol. 2011;69:141&#x2013;151. doi: 10.1002/ana.22149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22149</ArticleId><ArticleId IdType="pmc">PMC3052883</ArticleId><ArticleId IdType="pubmed">21280084</ArticleId></ArticleIdList></Reference><Reference><Citation>Manghera M., Ferguson-Parry J., Douville R.N. TDP-43 regulates endogenous retrovirus-K viral protein accumulation. Neurobiol. Dis. 2016;94:226&#x2013;236. doi: 10.1016/j.nbd.2016.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.06.017</ArticleId><ArticleId IdType="pubmed">27370226</ArticleId></ArticleIdList></Reference><Reference><Citation>Manghera M., Ferguson-Parry J., Lin R., Douville R.N. NF-kappaB and IRF1 Induce Endogenous Retrovirus K Expression via Interferon-Stimulated Response Elements in Its 5&#x2032; Long Terminal Repeat. J. Virol. 2016;90:9338&#x2013;9349. doi: 10.1128/JVI.01503-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01503-16</ArticleId><ArticleId IdType="pmc">PMC5044829</ArticleId><ArticleId IdType="pubmed">27512062</ArticleId></ArticleIdList></Reference><Reference><Citation>Arru G., Mameli G., Deiana G.A., Rassu A.L., Piredda R., Sechi E., Caggiu E., Bo M., Nako E., Urso D., et al. Humoral immunity response to human endogenous retroviruses K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases. Eur. J. Neurol. 2018;25:1076-e1084. doi: 10.1111/ene.13648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13648</ArticleId><ArticleId IdType="pubmed">29603839</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Lee M.H., Henderson L., Tyagi R., Bachani M., Steiner J., Campanac E., Hoffman D.A., von Geldern G., Johnson K., et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci. Transl. Med. 2015;7:307ra153. doi: 10.1126/scitranslmed.aac8201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac8201</ArticleId><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer J., Harz C., Sanchez L., Pereira G.C., Maldener E., Heras S.R., Ostrow L.W., Ravits J., Batra R., Meese E., et al. Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins. Mol. Neurodegener. 2018;13:39. doi: 10.1186/s13024-018-0275-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0275-3</ArticleId><ArticleId IdType="pmc">PMC6091006</ArticleId><ArticleId IdType="pubmed">30068350</ArticleId></ArticleIdList></Reference><Reference><Citation>Garson J.A., Usher L., Al-Chalabi A., Huggett J., Day E.F., McCormick A.L. Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2019;7:45. doi: 10.1186/s40478-019-0698-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0698-2</ArticleId><ArticleId IdType="pmc">PMC6421708</ArticleId><ArticleId IdType="pubmed">30885274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat R.K., Rudnick W., Antony J.M., Maingat F., Ellestad K.K., Wheatley B.M., Tonjes R.R., Power C. Human Endogenous Retrovirus-K(II) Envelope Induction Protects Neurons during HIV/AIDS. PLoS ONE. 2014;9:e97984. doi: 10.1371/journal.pone.0097984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0097984</ArticleId><ArticleId IdType="pmc">PMC4079299</ArticleId><ArticleId IdType="pubmed">24988390</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A., Braak H., Del Tredici K., Lemon R., Ludolph A.C., Kiernan M.C. Cortical influences drive amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2017;88:917&#x2013;924. doi: 10.1136/jnnp-2017-315573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315573</ArticleId><ArticleId IdType="pubmed">28710326</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappello V., Francolini M. Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2017;18:2092. doi: 10.3390/ijms18102092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102092</ArticleId><ArticleId IdType="pmc">PMC5666774</ArticleId><ArticleId IdType="pubmed">28972545</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisse K., Strong M.J. Innate immunity in amyotrophic lateral sclerosis. Biochim. Biophys. Acta. 2006;1762:1083&#x2013;1093. doi: 10.1016/j.bbadis.2006.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.03.001</ArticleId><ArticleId IdType="pubmed">16624536</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Henderson R.D. The Role of immune and inflammatory mechanisms in ALS. Curr. Mol. Med. 2011;11:246&#x2013;254. doi: 10.2174/156652411795243450.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652411795243450</ArticleId><ArticleId IdType="pmc">PMC3182412</ArticleId><ArticleId IdType="pubmed">21375489</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquette Y., Hanna Z., Savard P., Brousseau R., Robitaille Y., Jolicoeur P. Retrovirus-induced murine motor neuron disease: Mapping the determinant of spongiform degeneration within the envelope gene. Proc. Natl. Acad. Sci. USA. 1989;86:3896&#x2013;3900. doi: 10.1073/pnas.86.10.3896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.86.10.3896</ArticleId><ArticleId IdType="pmc">PMC287248</ArticleId><ArticleId IdType="pubmed">2542954</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen L.N., Tyagi R., Li W., Alfahad T., Smith B., Wright M., Singer E.J., Nath A. HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy. Neurology. 2016;87:1756&#x2013;1762. doi: 10.1212/WNL.0000000000003258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003258</ArticleId><ArticleId IdType="pmc">PMC5089528</ArticleId><ArticleId IdType="pubmed">27664983</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGowan D.J., Scelsa S.N., Waldron M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. 2001;57:1094&#x2013;1097. doi: 10.1212/WNL.57.6.1094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.6.1094</ArticleId><ArticleId IdType="pubmed">11571341</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva M.T., Leite A.C., Alamy A.H., Chimelli L., Andrada-Serpa M.J., Araujo A.Q. ALS syndrome in HTLV-I infection. Neurology. 2005;65:1332&#x2013;1333. doi: 10.1212/01.wnl.0000180962.47653.5e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000180962.47653.5e</ArticleId><ArticleId IdType="pubmed">16247078</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Montojo M., Doucet-O&#x2019;Hare T., Henderson L., Nath A. Human endogenous retrovirus-K (HML-2): A comprehensive review. Crit. Rev. Microbiol. 2018;44:715&#x2013;738. doi: 10.1080/1040841X.2018.1501345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1040841X.2018.1501345</ArticleId><ArticleId IdType="pmc">PMC6342650</ArticleId><ArticleId IdType="pubmed">30318978</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss R.A. The discovery of endogenous retroviruses. Retrovirology. 2006;3:67. doi: 10.1186/1742-4690-3-67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-3-67</ArticleId><ArticleId IdType="pmc">PMC1617120</ArticleId><ArticleId IdType="pubmed">17018135</ArticleId></ArticleIdList></Reference><Reference><Citation>Macfarlane C., Simmonds P. Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations. J. Mol. Evol. 2004;59:642&#x2013;656. doi: 10.1007/s00239-004-2656-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00239-004-2656-1</ArticleId><ArticleId IdType="pubmed">15693620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokossou A.G., Toudic C., Barbeau B. Implication of human endogenous retrovirus envelope proteins in placental functions. Viruses. 2014;6:4609&#x2013;4627. doi: 10.3390/v6114609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6114609</ArticleId><ArticleId IdType="pmc">PMC4246240</ArticleId><ArticleId IdType="pubmed">25421890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohn O., Hanke K., Bannert N. HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease. Front. Oncol. 2013;3:246. doi: 10.3389/fonc.2013.00246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2013.00246</ArticleId><ArticleId IdType="pmc">PMC3778440</ArticleId><ArticleId IdType="pubmed">24066280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860&#x2013;921. doi: 10.1038/35057062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35057062</ArticleId><ArticleId IdType="pubmed">11237011</ArticleId></ArticleIdList></Reference><Reference><Citation>Seifarth W., Frank O., Zeilfelder U., Spiess B., Greenwood A.D., Hehlmann R., Leib-Mosch C. Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J. Virol. 2005;79:341&#x2013;352. doi: 10.1128/JVI.79.1.341-352.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.1.341-352.2005</ArticleId><ArticleId IdType="pmc">PMC538696</ArticleId><ArticleId IdType="pubmed">15596828</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandi N., Tramontano E. HERV Envelope Proteins: Physiological Role and Pathogenic Potential in Cancer and Autoimmunity. Front. Microbiol. 2018;9:462. doi: 10.3389/fmicb.2018.00462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00462</ArticleId><ArticleId IdType="pmc">PMC5861771</ArticleId><ArticleId IdType="pubmed">29593697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajasin D., Eugenin E.A. HIV-1 Tat: Role in Bystander Toxicity. Front. Cell. Infect. Microbiol. 2020;10:61. doi: 10.3389/fcimb.2020.00061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00061</ArticleId><ArticleId IdType="pmc">PMC7052126</ArticleId><ArticleId IdType="pubmed">32158701</ArticleId></ArticleIdList></Reference><Reference><Citation>Spector C., Mele A.R., Wigdahl B., Nonnemacher M.R. Genetic variation and function of the HIV-1 Tat protein. Med. Microbiol. Immunol. 2019;208:131&#x2013;169. doi: 10.1007/s00430-019-00583-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-019-00583-z</ArticleId><ArticleId IdType="pmc">PMC6476422</ArticleId><ArticleId IdType="pubmed">30834965</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao B., Peng C., Yang J., Yi Y., Zhang J., Shi Q. Cone Snails: A Big Store of Conotoxins for Novel Drug Discovery. Toxins. 2017;9:397. doi: 10.3390/toxins9120397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins9120397</ArticleId><ArticleId IdType="pmc">PMC5744117</ArticleId><ArticleId IdType="pubmed">29215605</ArticleId></ArticleIdList></Reference><Reference><Citation>Obafemi A., Roth B. Prolonged delirium with psychotic features from omega conotoxin toxicity. Pain Med. 2013;14:447&#x2013;448. doi: 10.1111/pme.12005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pme.12005</ArticleId><ArticleId IdType="pubmed">23383992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda M., Shikata M., Shirata N., Chaeychomsri S., Kobayashi M. Gene organization and complete sequence of the Hyphantria cunea nucleopolyhedrovirus genome. J. Gen. Virol. 2006;87:2549&#x2013;2562. doi: 10.1099/vir.0.81930-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81930-0</ArticleId><ArticleId IdType="pubmed">16894193</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S., Darbon H., Dyason K., Verdonck F., Tytgat J. Evolutionary origin of inhibitor cystine knot peptides. FASEB J. 2003;17:1765&#x2013;1767. doi: 10.1096/fj.02-1044fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.02-1044fje</ArticleId><ArticleId IdType="pubmed">12958203</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldridge R., Li Y., Miller L.K. Characterization of a baculovirus gene encoding a small conotoxinlike polypeptide. J. Virol. 1992;66:6563&#x2013;6571. doi: 10.1128/JVI.66.11.6563-6571.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.66.11.6563-6571.1992</ArticleId><ArticleId IdType="pmc">PMC240151</ArticleId><ArticleId IdType="pubmed">1404603</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly N.L., Craik D.J. Bioactive cystine knot proteins. Curr. Opin. Chem. Biol. 2011;15:362&#x2013;368. doi: 10.1016/j.cbpa.2011.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2011.02.008</ArticleId><ArticleId IdType="pubmed">21362584</ArticleId></ArticleIdList></Reference><Reference><Citation>Postic G., Gracy J., Perin C., Chiche L., Gelly J.C. KNOTTIN: The database of inhibitor cystine knot scaffold after 10 years, toward a systematic structure modeling. Nucleic Acids Res. 2018;46:D454&#x2013;D458. doi: 10.1093/nar/gkx1084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1084</ArticleId><ArticleId IdType="pmc">PMC5753296</ArticleId><ArticleId IdType="pubmed">29136213</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez D., Gonzalez W., Fissore R.A., Carvacho I. Conotoxins as Tools to Understand the Physiological Function of Voltage-Gated Calcium (CaV) Channels. Mar. Drugs. 2017;15:313. doi: 10.3390/md15100313.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md15100313</ArticleId><ArticleId IdType="pmc">PMC5666421</ArticleId><ArticleId IdType="pubmed">29027927</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourinet E., Zamponi G.W. Block of voltage-gated calcium channels by peptide toxins. Neuropharmacology. 2017;127:109&#x2013;115. doi: 10.1016/j.neuropharm.2016.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.10.016</ArticleId><ArticleId IdType="pubmed">27756538</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang F. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications. Front. Immunol. 2017;8:1005. doi: 10.3389/fimmu.2017.01005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01005</ArticleId><ArticleId IdType="pmc">PMC5567007</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Chen H.J., Shaw C.E. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Neurotherapeutics. 2015;12:352&#x2013;363. doi: 10.1007/s13311-015-0338-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhuriya Y.K., Sharma D. Necroptosis: A regulated inflammatory mode of cell death. J. Neuroinflammation. 2018;15:199. doi: 10.1186/s12974-018-1235-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1235-0</ArticleId><ArticleId IdType="pmc">PMC6035417</ArticleId><ArticleId IdType="pubmed">29980212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T., Ahmad T.K., Gozda K., Truong J., Kong J., Namaka M. Implications of white matter damage in amyotrophic lateral sclerosis (Review) Mol. Med. Rep. 2017;16:4379&#x2013;4392. doi: 10.3892/mmr.2017.7186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.7186</ArticleId><ArticleId IdType="pmc">PMC5646997</ArticleId><ArticleId IdType="pubmed">28791401</ArticleId></ArticleIdList></Reference><Reference><Citation>Tognatta R., Miller R.H. Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies. Neuropharmacology. 2016;110:539&#x2013;547. doi: 10.1016/j.neuropharm.2016.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.04.026</ArticleId><ArticleId IdType="pmc">PMC5512544</ArticleId><ArticleId IdType="pubmed">27108096</ArticleId></ArticleIdList></Reference><Reference><Citation>Manghera M., Ferguson J., Douville R. ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease. Viruses. 2015;7:320&#x2013;332. doi: 10.3390/v7010320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7010320</ArticleId><ArticleId IdType="pmc">PMC4306841</ArticleId><ArticleId IdType="pubmed">25609305</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull M.G., Douville R.N. Related Endogenous Retrovirus-K Elements Harbor Distinct Protease Active Site Motifs. Front. Microbiol. 2018;9:1577. doi: 10.3389/fmicb.2018.01577.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.01577</ArticleId><ArticleId IdType="pmc">PMC6058741</ArticleId><ArticleId IdType="pubmed">30072963</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Curzio D.L., Buist R.J., Del Bigio M.R. Reduced subventricular zone proliferation and white matter damage in juvenile ferrets with kaolin-induced hydrocephalus. Exp. Neurol. 2013;248:112&#x2013;128. doi: 10.1016/j.expneurol.2013.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.06.004</ArticleId><ArticleId IdType="pubmed">23769908</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins J.F., Loughran G., Bhatt P.R., Firth A.E., Baranov P.V. Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use. Nucleic Acids Res. 2016;44:7007&#x2013;7078. doi: 10.1093/nar/gkw530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw530</ArticleId><ArticleId IdType="pmc">PMC5009743</ArticleId><ArticleId IdType="pubmed">27436286</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck C.B., Shen X., Egan M.A., Pierson T.C., Walker C.M., Siliciano R.F. The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. J. Virol. 2001;75:181&#x2013;191. doi: 10.1128/JVI.75.1.181-191.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.1.181-191.2001</ArticleId><ArticleId IdType="pmc">PMC113911</ArticleId><ArticleId IdType="pubmed">11119587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hidalgo L., Swanson C.M. Regulation of human immunodeficiency virus type 1 (HIV-1) mRNA translation. Biochem. Soc. Trans. 2017;45:353&#x2013;364. doi: 10.1042/BST20160357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20160357</ArticleId><ArticleId IdType="pubmed">28408475</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K.C. Revealing -1 programmed ribosomal frameshifting mechanisms by single-molecule techniques and computational methods. Comput. Math. Methods Med. 2012;2012:569870. doi: 10.1155/2012/569870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/569870</ArticleId><ArticleId IdType="pmc">PMC3321566</ArticleId><ArticleId IdType="pubmed">22545064</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacks T., Townsley K., Varmus H.E., Majors J. Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins. Proc. Natl. Acad. Sci. USA. 1987;84:4298&#x2013;4302. doi: 10.1073/pnas.84.12.4298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.84.12.4298</ArticleId><ArticleId IdType="pmc">PMC305072</ArticleId><ArticleId IdType="pubmed">3035577</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulikas T. Putative nuclear localization signals (NLS) in protein transcription factors. J. Cell Biochem. 1994;55:32&#x2013;58. doi: 10.1002/jcb.240550106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.240550106</ArticleId><ArticleId IdType="pubmed">8083298</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewannieux M., Blaise S., Heidmann T. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J. Virol. 2005;79:15573&#x2013;15577. doi: 10.1128/JVI.79.24.15573-15577.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.24.15573-15577.2005</ArticleId><ArticleId IdType="pmc">PMC1315997</ArticleId><ArticleId IdType="pubmed">16306628</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson S.D., Norton R.S. Conotoxin gene superfamilies. Mar. Drugs. 2014;12:6058&#x2013;6101. doi: 10.3390/md12126058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md12126058</ArticleId><ArticleId IdType="pmc">PMC4278219</ArticleId><ArticleId IdType="pubmed">25522317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K., Raymond C., Martin-Moutot N., Sasaki T., Ohtake A., Minami K., Van Renterghem C., Kim J.I., Takahashi M., Seagar M.J. Binding of Ala-scanning analogs of omega-conotoxin MVIIC to N- and P/Q-type calcium channels. FEBS Lett. 2000;469:147&#x2013;150. doi: 10.1016/S0014-5793(00)01263-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(00)01263-1</ArticleId><ArticleId IdType="pubmed">10713260</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand S.J., Aksenova M.V., Mactutus C.F., Booze R.M. HIV-1 Tat protein variants: Critical role for the cysteine region in synaptodendritic injury. Exp. Neurol. 2013;248:228&#x2013;235. doi: 10.1016/j.expneurol.2013.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.06.020</ArticleId><ArticleId IdType="pmc">PMC3773475</ArticleId><ArticleId IdType="pubmed">23811015</ArticleId></ArticleIdList></Reference><Reference><Citation>Devadas K., Boykins R.A., Hardegen N.J., Philp D., Kleinman H.K., Osa E.O., Wang J., Clouse K.A., Wahl L.M., Hewlett I.K., et al. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides. Peptides. 2006;27:611&#x2013;621. doi: 10.1016/j.peptides.2005.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2005.09.013</ArticleId><ArticleId IdType="pubmed">16256245</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiume G., Vecchio E., De Laurentiis A., Trimboli F., Palmieri C., Pisano A., Falcone C., Pontoriero M., Rossi A., Scialdone A., et al. Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65. Nucleic Acids Res. 2012;40:3548&#x2013;3562. doi: 10.1093/nar/gkr1224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr1224</ArticleId><ArticleId IdType="pmc">PMC3333881</ArticleId><ArticleId IdType="pubmed">22187158</ArticleId></ArticleIdList></Reference><Reference><Citation>Manghera M., Douville R.N. Endogenous retrovirus-K promoter: A landing strip for inflammatory transcription factors? Retrovirology. 2013;10:16. doi: 10.1186/1742-4690-10-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-10-16</ArticleId><ArticleId IdType="pmc">PMC3598470</ArticleId><ArticleId IdType="pubmed">23394165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong P.D., Doyle M.L., Casper D.J., Cicala C., Leavitt S.A., Majeed S., Steenbeke T.D., Venturi M., Chaiken I., Fung M., et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature. 2002;420:678&#x2013;682. doi: 10.1038/nature01188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01188</ArticleId><ArticleId IdType="pubmed">12478295</ArticleId></ArticleIdList></Reference><Reference><Citation>Szilagyi A., Skolnick J. Efficient prediction of nucleic acid binding function from low-resolution protein structures. J. Mol. Biol. 2006;358:922&#x2013;933. doi: 10.1016/j.jmb.2006.02.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2006.02.053</ArticleId><ArticleId IdType="pubmed">16551468</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhamija N., Choudhary D., Ladha J.S., Pillai B., Mitra D. Tat predominantly associates with host promoter elements in HIV-1-infected T-cells&#x2014;regulatory basis of transcriptional repression of c-Rel. FEBS J. 2015;282:595&#x2013;610. doi: 10.1111/febs.13168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13168</ArticleId><ArticleId IdType="pubmed">25472883</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo J.Y., Yaneva R., Cresswell P. Viperin: A multifunctional, interferon-inducible protein that regulates virus replication. Cell Host Microbe. 2011;10:534&#x2013;539. doi: 10.1016/j.chom.2011.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.11.004</ArticleId><ArticleId IdType="pmc">PMC3246677</ArticleId><ArticleId IdType="pubmed">22177558</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieda K., Hoffmann A., Boller K. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J. Gen. Virol. 2001;82:591&#x2013;596. doi: 10.1099/0022-1317-82-3-591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-82-3-591</ArticleId><ArticleId IdType="pubmed">11172100</ArticleId></ArticleIdList></Reference><Reference><Citation>Golan M., Hizi A., Resau J.H., Yaal-Hahoshen N., Reichman H., Keydar I., Tsarfaty I. Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia. 2008;10:521&#x2013;533. doi: 10.1593/neo.07986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1593/neo.07986</ArticleId><ArticleId IdType="pmc">PMC2386537</ArticleId><ArticleId IdType="pubmed">18516289</ArticleId></ArticleIdList></Reference><Reference><Citation>Re D.B., Le Verche V., Yu C., Amoroso M.W., Politi K.A., Phani S., Ikiz B., Hoffmann L., Koolen M., Nagata T., et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81:1001&#x2013;1008. doi: 10.1016/j.neuron.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Degterev A., Ofengeim D., Yuan J. Targeting RIPK1 for the treatment of human diseases. Proc. Natl. Acad. Sci. USA. 2019;116:9714&#x2013;9722. doi: 10.1073/pnas.1901179116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1901179116</ArticleId><ArticleId IdType="pmc">PMC6525537</ArticleId><ArticleId IdType="pubmed">31048504</ArticleId></ArticleIdList></Reference><Reference><Citation>Dondelinger Y., Declercq W., Montessuit S., Roelandt R., Goncalves A., Bruggeman I., Hulpiau P., Weber K., Sehon C.A., Marquis R.W., et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 2014;7:971&#x2013;981. doi: 10.1016/j.celrep.2014.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.04.026</ArticleId><ArticleId IdType="pubmed">24813885</ArticleId></ArticleIdList></Reference><Reference><Citation>Belizario J., Vieira-Cordeiro L., Enns S. Necroptotic Cell Death Signaling and Execution Pathway: Lessons from Knockout Mice. Mediators Inflamm. 2015;2015:128076. doi: 10.1155/2015/128076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/128076</ArticleId><ArticleId IdType="pmc">PMC4600508</ArticleId><ArticleId IdType="pubmed">26491219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonneman A., Robberecht W., Van Den Bosch L. The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis. Neurodegener. Dis. Manag. 2014;4:223&#x2013;239. doi: 10.2217/nmt.14.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt.14.21</ArticleId><ArticleId IdType="pubmed">25095817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.D., Borasio G.D. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031&#x2013;2041. doi: 10.1016/S0140-6736(07)60944-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60944-1</ArticleId><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>McTigue D.M., Tripathi R.B. The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 2008;107:1&#x2013;19. doi: 10.1111/j.1471-4159.2008.05570.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05570.x</ArticleId><ArticleId IdType="pubmed">18643793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying Z., Pan C., Shao T., Liu L., Li L., Guo D., Zhang S., Yuan T., Cao R., Jiang Z., et al. Mixed Lineage Kinase Domain-like Protein MLKL Breaks Down Myelin following Nerve Injury. Mol. Cell. 2018;72:457.e455&#x2013;468.e455. doi: 10.1016/j.molcel.2018.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.09.011</ArticleId><ArticleId IdType="pubmed">30344099</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan X., Jickling G.C., Ander B.P., Liu D., Stamova B., Cox C., Jin L.W., DeCarli C., Sharp F.R. Myelin injury and degraded myelin vesicles in Alzheimer&#x2019;s disease. Curr. Alzheimer Res. 2014;11:232&#x2013;238. doi: 10.2174/1567205011666140131120922.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205011666140131120922</ArticleId><ArticleId IdType="pmc">PMC4066812</ArticleId><ArticleId IdType="pubmed">24484278</ArticleId></ArticleIdList></Reference><Reference><Citation>Othman A., Frim D.M., Polak P., Vujicic S., Arnason B.G., Boullerne A.I. Olig1 is expressed in human oligodendrocytes during maturation and regeneration. Glia. 2011;59:914&#x2013;926. doi: 10.1002/glia.21163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21163</ArticleId><ArticleId IdType="pubmed">21446039</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins T.A., Emery B., Mulinyawe S., Barres B.A. Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron. 2008;60:555&#x2013;569. doi: 10.1016/j.neuron.2008.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.09.011</ArticleId><ArticleId IdType="pmc">PMC2650711</ArticleId><ArticleId IdType="pubmed">19038214</ArticleId></ArticleIdList></Reference><Reference><Citation>de Faria O., Jr., Gonsalvez D., Nicholson M., Xiao J. Activity-dependent central nervous system myelination throughout life. J. Neurochem. 2018;148:447&#x2013;461. doi: 10.1111/jnc.14592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14592</ArticleId><ArticleId IdType="pmc">PMC6587454</ArticleId><ArticleId IdType="pubmed">30225984</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett H.A., Fancy S.P., Alberta J.A., Zhao C., Plant S.R., Kaing S., Raine C.S., Rowitch D.H., Franklin R.J., Stiles C.D. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science. 2004;306:2111&#x2013;2115. doi: 10.1126/science.1103709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1103709</ArticleId><ArticleId IdType="pubmed">15604411</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmandke A., Schmandke A., Schwab M.E. Nogo-A: Multiple Roles in CNS Development, Maintenance, and Disease. Neuroscientist. 2014;20:372&#x2013;386. doi: 10.1177/1073858413516800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858413516800</ArticleId><ArticleId IdType="pubmed">24402613</ArticleId></ArticleIdList></Reference><Reference><Citation>Pernet V., Joly S., Christ F., Dimou L., Schwab M.E. Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J. Neurosci. 2008;28:7435&#x2013;7444. doi: 10.1523/JNEUROSCI.0727-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0727-08.2008</ArticleId><ArticleId IdType="pmc">PMC6670388</ArticleId><ArticleId IdType="pubmed">18632947</ArticleId></ArticleIdList></Reference><Reference><Citation>Miron V.E., Kuhlmann T., Antel J.P. Cells of the oligodendroglial lineage, myelination, and remyelination. Biochim. Biophys. Acta. 2011;1812:184&#x2013;193. doi: 10.1016/j.bbadis.2010.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2010.09.010</ArticleId><ArticleId IdType="pubmed">20887785</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhlmann T., Miron V., Cui Q., Wegner C., Antel J., Bruck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain. 2008;131:1749&#x2013;1758. doi: 10.1093/brain/awn096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn096</ArticleId><ArticleId IdType="pubmed">18515322</ArticleId></ArticleIdList></Reference><Reference><Citation>Buss A., Pech K., Merkler D., Kakulas B.A., Martin D., Schoenen J., Noth J., Schwab M.E., Brook G.A. Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord. Brain. 2005;128:356&#x2013;364. doi: 10.1093/brain/awh355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh355</ArticleId><ArticleId IdType="pubmed">15634734</ArticleId></ArticleIdList></Reference><Reference><Citation>Morozov V.A., Dao Thi V.L., Denner J. The transmembrane protein of the human endogenous retrovirus--K (HERV-K) modulates cytokine release and gene expression. PLoS ONE. 2013;8:e70399. doi: 10.1371/journal.pone.0070399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0070399</ArticleId><ArticleId IdType="pmc">PMC3737193</ArticleId><ArticleId IdType="pubmed">23950929</ArticleId></ArticleIdList></Reference><Reference><Citation>Buscher K., Hahn S., Hofmann M., Trefzer U., Ozel M., Sterry W., Lower J., Lower R., Kurth R., Denner J. Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res. 2006;16:223&#x2013;234. doi: 10.1097/01.cmr.0000215031.07941.ca.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.cmr.0000215031.07941.ca</ArticleId><ArticleId IdType="pubmed">16718269</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson L.R., Whelan S.P. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein. J. Virol. 2016;90:3640&#x2013;3649. doi: 10.1128/JVI.03136-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03136-15</ArticleId><ArticleId IdType="pmc">PMC4794671</ArticleId><ArticleId IdType="pubmed">26792739</ArticleId></ArticleIdList></Reference><Reference><Citation>Caller T.A., Field N.C., Chipman J.W., Shi X., Harris B.T., Stommel E.W. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA. Amyotroph. Lateral Scler. 2012;13:25&#x2013;32. doi: 10.3109/17482968.2011.621436.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.621436</ArticleId><ArticleId IdType="pubmed">22214351</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang H., Liu G., Jiang Y., Fu J., Zhang B., Song R., Wang W. Pathway analysis of two amyotrophic lateral sclerosis GWAS highlights shared genetic signals with Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease. Mol. Neurobiol. 2015;51:361&#x2013;369. doi: 10.1007/s12035-014-8673-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8673-1</ArticleId><ArticleId IdType="pubmed">24647822</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Bender D.E., Delaney C.E., Cataldo M.D., Smith A.L., Yung R., Ruden D.M., Callaghan B.C., Feldman E.L. Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e52672. doi: 10.1371/journal.pone.0052672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052672</ArticleId><ArticleId IdType="pmc">PMC3530456</ArticleId><ArticleId IdType="pubmed">23300739</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., Baloh R.H. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137:715&#x2013;730. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell S.J., Cosset F.L. Modifying the host range properties of retroviral vectors. J. Gene Med. 1999;1:300&#x2013;311. doi: 10.1002/(SICI)1521-2254(199909/10)1:5&lt;300::AID-JGM59&gt;3.0.CO;2-T.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1521-2254(199909/10)1:5&lt;300::AID-JGM59&gt;3.0.CO;2-T</ArticleId><ArticleId IdType="pubmed">10738547</ArticleId></ArticleIdList></Reference><Reference><Citation>Yolitz J., Schwing C., Chang J., Van Ryk D., Nawaz F., Wei D., Cicala C., Arthos J., Fauci A.S. Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120. Proc. Natl. Acad. Sci. USA. 2018;115:2443&#x2013;2448. doi: 10.1073/pnas.1722627115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1722627115</ArticleId><ArticleId IdType="pmc">PMC5877976</ArticleId><ArticleId IdType="pubmed">29463753</ArticleId></ArticleIdList></Reference><Reference><Citation>Cestra G., Rossi S., Di Salvio M., Cozzolino M. Control of mRNA Translation in ALS Proteinopathy. Front. Molecul. Neurosci. 2017;10:85. doi: 10.3389/fnmol.2017.00085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00085</ArticleId><ArticleId IdType="pmc">PMC5362592</ArticleId><ArticleId IdType="pubmed">28386218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 2016;138(Suppl. 1):95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueki N., Someya K., Matsuo Y., Wakamatsu K., Mukai H. Cryptides: Functional cryptic peptides hidden in protein structures. Biopolymers. 2007;88:190&#x2013;198. doi: 10.1002/bip.20687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.20687</ArticleId><ArticleId IdType="pubmed">17245751</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermentzaki G., Politi K.A., Lu L., Mishra V., Perez-Torres E.J., Sosunov A.A., McKhann G.M., 2nd, Lotti F., Shneider N.A., Przedborski S. Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo. eNeuro. 2019;6 doi: 10.1523/ENEURO.0308-18.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0308-18.2018</ArticleId><ArticleId IdType="pmc">PMC6391588</ArticleId><ArticleId IdType="pubmed">30815534</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Perera N.D., Chiam M.D.F., Cuic B., Wanniarachchillage N., Tomas D., Samson A.L., Cawthorne W., Valor E.N., Murphy J.M., et al. Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS. Cell Death Differ. 2020;27:1728&#x2013;1739. doi: 10.1038/s41418-019-0457-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-019-0457-8</ArticleId><ArticleId IdType="pmc">PMC7206015</ArticleId><ArticleId IdType="pubmed">31745214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente Pons A., Higginbottom A., Cooper-Knock J., Alrafiah A., Alofi E., Kirby J., Shaw P.J., Wood J.D., Highley J.R. Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. J. Pathol. 2020 doi: 10.1002/path.5455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5455</ArticleId><ArticleId IdType="pubmed">32391572</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G., Bauche S., Gonzalez de Aguilar J.L., Brochier G., Mandjee N., Tanguy M.L., Hussain G., Behin A., Khiami F., Sariali E., et al. Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Ann. Clin. Transl. Neurol. 2015;2:362&#x2013;372. doi: 10.1002/acn3.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.179</ArticleId><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.F., Bruneteau G., Gonzalez de Aguilar J.L., Dupuis L., Jokic N., Salachas F., Le Forestier N., Echaniz-Laguna A., Dubourg O., Hauw J.J., et al. Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes. Ann. Neurol. 2007;62:15&#x2013;20. doi: 10.1002/ana.21122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21122</ArticleId><ArticleId IdType="pubmed">17455292</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.W., Yang J.F., Ma Y., Hua Z., Guo Y., Gu X.L., Zhang Y.F. Nogo-A expression dynamically varies after spinal cord injury. Neural Regen. Res. 2015;10:225&#x2013;229. doi: 10.4103/1673-5374.152375.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.152375</ArticleId><ArticleId IdType="pmc">PMC4392669</ArticleId><ArticleId IdType="pubmed">25883620</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hare Doig R.L., Chiha W., Giacci M.K., Yates N.J., Bartlett C.A., Smith N.M., Hodgetts S.I., Harvey A.R., Fitzgerald M. Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma. BMC Neurosci. 2017;18:62. doi: 10.1186/s12868-017-0380-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12868-017-0380-1</ArticleId><ArticleId IdType="pmc">PMC5557315</ArticleId><ArticleId IdType="pubmed">28806920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Yoon J.H., Kim Y.S. HIV-1 Tat interacts with and regulates the localization and processing of amyloid precursor protein. PLoS ONE. 2013;8:e77972. doi: 10.1371/journal.pone.0077972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077972</ArticleId><ArticleId IdType="pmc">PMC3843664</ArticleId><ArticleId IdType="pubmed">24312169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruman I.I., Nath A., Mattson M.P. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp. Neurol. 1998;154:276&#x2013;288. doi: 10.1006/exnr.1998.6958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1998.6958</ArticleId><ArticleId IdType="pubmed">9878167</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagashev A., Sawaya B.E. Roles and functions of HIV-1 Tat protein in the CNS: An overview. Virol. J. 2013;10:358. doi: 10.1186/1743-422X-10-358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-358</ArticleId><ArticleId IdType="pmc">PMC3879180</ArticleId><ArticleId IdType="pubmed">24359561</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou S., Fuss B., Fitting S., Hahn Y.K., Hauser K.F., Knapp P.E. Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development. J. Neurosci. 2015;35:11384&#x2013;11398. doi: 10.1523/JNEUROSCI.4740-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4740-14.2015</ArticleId><ArticleId IdType="pmc">PMC4532766</ArticleId><ArticleId IdType="pubmed">26269645</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Dahiya S., Kortagere S., Aiamkitsumrit B., Cunningham D., Pirrone V., Nonnemacher M.R., Wigdahl B. Impact of Tat Genetic Variation on HIV-1 Disease. Adv. Virol. 2012;2012:123605. doi: 10.1155/2012/123605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/123605</ArticleId><ArticleId IdType="pmc">PMC3414192</ArticleId><ArticleId IdType="pubmed">22899925</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark E., Nava B., Caputi M. Tat is a multifunctional viral protein that modulates cellular gene expression and functions. Oncotarget. 2017;8:27569&#x2013;27581. doi: 10.18632/oncotarget.15174.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.15174</ArticleId><ArticleId IdType="pmc">PMC5432358</ArticleId><ArticleId IdType="pubmed">28187438</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Hernandez M.J., Cavalcoli J.D., Sartor M.A., Contreras-Galindo R., Meng F., Dai M., Dube D., Saha A.K., Gitlin S.D., Omenn G.S., et al. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein. J. Virol. 2014;88:8924&#x2013;8935. doi: 10.1128/JVI.00556-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00556-14</ArticleId><ArticleId IdType="pmc">PMC4136263</ArticleId><ArticleId IdType="pubmed">24872592</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabarrini O., Desantis J., Massari S. Recent advances in the identification of Tat-mediated transactivation inhibitors: Progressing toward a functional cure of HIV. Future Med. Chem. 2016;8:421&#x2013;442. doi: 10.4155/fmc.16.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc.16.3</ArticleId><ArticleId IdType="pubmed">26933891</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>